Age-Related Differences in the Prognosis of Pancreatic Cancer According to Perioperative Systemic Therapy-Reference-Cited by-同舟云学术

Age-Related Differences in the Prognosis of Pancreatic Cancer According to Perioperative Systemic Therapy

Published:2021-01 Issue:1 Volume:50 Page:37-46
ISSN:1536-4828
Container-title:Pancreas
language:en
Short-container-title:Pancreas

Author:

Sonohara Fuminori,Yamada Suguru,Kurimoto Keisuke,Inokawa Yoshikuni,Takami Hideki,Hayashi Masamichi,Shimizu Dai,Hattori Norifumi,Kanda Mitsuro,Tanaka Chie,Nakayama Goro,Koike Masahiko,Fujii Tsutomu,Kodera Yasuhiro

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Endocrinology,Hepatology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference43 articles.

1. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States;Cancer Res,2014

2. Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer;Ann Surg,2015

3. Effect of neoadjuvant nab-paclitaxel plus gemcitabine therapy on overall survival in patients with borderline resectable pancreatic cancer: a prospective multicenter phase II trial (NAC-GA Trial);Oncology,2017

4. Survival outcomes associated with clinical and pathological response following neoadjuvant FOLFIRINOX or gemcitabine/nab-paclitaxel chemotherapy in resected pancreatic cancer;Ann Surg,2019

5. Impact of FOLFIRINOX compared with gemcitabine on quality of life in patients with metastatic pancreatic cancer: results from the PRODIGE 4/ACCORD 11 randomized trial;J Clin Oncol,2013

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Changes in Skeletal Muscle Volume During Preoperative Chemotherapy Affect the Outcome of Pancreatic Cancer;The American Surgeon™;2024-08-24